Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

An infection of any surgically replaced joint represents a complex medical, social, and economic problem. Infection, and the complications therein, can represent a potential significant threat to a patient's limb, life, and livelihood. We explore the role of the microbiome in normal function and implications of dysbiosis in the development of periprosthetic joint infection; and the essential role of early accurate diagnosis and collaboration between surgeons, infectious diseases specialists/microbiologists and allied health teams. The management of prosthetic joint infections should take place in a multidisciplinary team (MDT). Despite the general principles of management outlined in this review, surgical and antimicrobial management is patient-specific, considering the cultured organism and its sensitivities, and the patient's overall health, comorbidities, their function, goals and expectations.

Original publication

DOI

10.1016/j.mpsur.2025.04.004

Type

Journal article

Journal

Surgery united kingdom

Publication Date

01/01/2025